Eli Lilly and Company today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca (pirtobrutinib), a non-covalent (reversible) Bruton tyrosine kinase (BTK) ...
Blood plasma is a necessary resource to produce life-saving medicine. Because people are the only source, donors are often ...
The world’s supply of many life-saving medications depends on people in the United States deciding to sell their blood plasma ...
A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...
Thinking of donating plasma in Lubbock? It's easier and more crucial than you think. This is the entire process—from the ...
Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates whole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback